{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:31:30Z","timestamp":1768458690085,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00277-015-2502-0","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T20:39:01Z","timestamp":1444250341000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Screening for viral hepatitis prior to rituximab chemotherapy"],"prefix":"10.1007","volume":"95","author":[{"given":"A. N.","family":"Leonard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-9143","authenticated-orcid":false,"given":"B. L.","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. B.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. N.","family":"Wallam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"2502_CR1","unstructured":"Disease burden from viral hepatitis A, B, and C in the United States; in CDC (ed). 2012,"},{"key":"2502_CR2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/gast.2001.22461","volume":"120","author":"RP Perrillo","year":"2001","unstructured":"Perrillo RP (2001) Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 120:1009\u20131022","journal-title":"Gastroenterology"},{"key":"2502_CR3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cgh.2006.05.027","volume":"4","author":"AL Mindikoglu","year":"2006","unstructured":"Mindikoglu AL, Regev A, Schiff ER (2006) Hepatitis b virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol 4:1076\u20131081","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2502_CR4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1634\/theoncologist.2010-0182","volume":"16","author":"C Leung","year":"2011","unstructured":"Leung C, Tsoi E, Burns G, Sievert W (2011) An argument for the universal prophylaxis of hepatitis B infection in patients receiving rituximab: a 7-year institutional experience of hepatitis screening. Oncologist 16:579\u2013584","journal-title":"Oncologist"},{"key":"2502_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000321792","volume":"125","author":"MG Kim","year":"2011","unstructured":"Kim MG, Park SY, Kim EJ, Kim YM, Kim HY, Lee YK, Zang DY, Kim HJ (2011) Hepatitis B virus reactivation in a primary central nervous system lymphoma patient following intrathecal rituximab treatment. Acta Haematol 125:121\u2013124","journal-title":"Acta Haematol"},{"key":"2502_CR6","first-page":"1","volume":"57","author":"CM Weinbaum","year":"2008","unstructured":"Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW (2008) Centers for disease C, prevention: recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 57:1\u201320","journal-title":"MMWR Recomm Rep"},{"key":"2502_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","volume":"50","author":"EAFTSOT Liver","year":"2009","unstructured":"Liver EAFTSOT (2009) EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 50:227\u2013242","journal-title":"J Hepatol"},{"key":"2502_CR8","unstructured":"Arzerra (ofatumumab) and rituxan (rituximab): drug safety communication\u2014new boxed warning. Recommendations to decrease risk of hepatitis b reactivation; in FDA (ed). Available at: http:\/\/www.fda.gov\/safety\/medwatch\/safetyinformation\/safetyalertsforhumanmedicalproducts\/ucm369846.htm"},{"key":"2502_CR9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.27609","volume":"61","author":"AM Bisceglie Di","year":"2015","unstructured":"Di Bisceglie AM, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH (2015) Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg? Hepatology 61:703\u2013711","journal-title":"Hepatology"},{"key":"2502_CR10","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","volume":"116","author":"D Ennishi","year":"2010","unstructured":"Ennishi D, Maeda Y, Niitsu N, Kojima M, Izutsu K, Takizawa J, Kusumoto S, Okamoto M, Yokoyama M, Takamatsu Y, Sunami K, Miyata A, Murayama K, Sakai A, Matsumoto M, Shinagawa K, Takaki A, Matsuo K, Kinoshita T, Tanimoto M (2010) Hepatic toxicity and prognosis in hepatitis c virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis. Blood 116:5119\u20135125","journal-title":"Blood"},{"key":"2502_CR11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2012.07.031","volume":"57","author":"P Mahale","year":"2012","unstructured":"Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA (2012) Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 57:1177\u20131185","journal-title":"J Hepatol"},{"key":"2502_CR12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.1999.17.1.394","volume":"17","author":"R Liang","year":"1999","unstructured":"Liang R, Lau GK, Kwong YL (1999) Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol 17:394\u2013398","journal-title":"J Clin Oncol"},{"key":"2502_CR13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJM197806222982502","volume":"298","author":"JH Hoofnagle","year":"1978","unstructured":"Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ (1978) Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298:1379\u20131383","journal-title":"N Engl J Med"},{"key":"2502_CR14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clinre.2011.07.018","volume":"36","author":"P Papamichalis","year":"2012","unstructured":"Papamichalis P, Alexiou A, Boulbou M, Dalekos GN, Rigopoulou EI (2012) Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy? Clin Res Hepatol Gastroenterol 36:84\u201393","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2502_CR15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1572-0241.2000.01854.x","volume":"95","author":"RC Cheung","year":"2000","unstructured":"Cheung RC (2000) Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 95:740\u2013747","journal-title":"Am J Gastroenterol"},{"key":"2502_CR16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1572-0241.2003.07176.x","volume":"98","author":"HB El-Serag","year":"2003","unstructured":"El-Serag HB, Anand B, Richardson P, Rabeneck L (2003) Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol 98:167\u2013174","journal-title":"Am J Gastroenterol"},{"key":"2502_CR17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","volume":"45","author":"AS Lok","year":"2007","unstructured":"Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45:507\u2013539","journal-title":"Hepatology"},{"key":"2502_CR18","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2010.30.0673","volume":"28","author":"AS Artz","year":"2010","unstructured":"Artz AS, Somerfield MR, Feld JJ, Giusti AF, Kramer BS, Sabichi AL, Zon RT, Wong SL (2010) American society of clinical oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol 28:3199\u20133202","journal-title":"J Clin Oncol"},{"key":"2502_CR19","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1200\/JOP.2011.000450","volume":"8","author":"JP Hwang","year":"2012","unstructured":"Hwang JP, Fisch MJ, Zhang H, Kallen MA, Routbort MJ, Lal LS, Vierling JM, Suarez-Almazor ME (2012) Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract \/ Am Soc Clin Oncol 8:e32\u2013e39","journal-title":"J Oncol Pract \/ Am Soc Clin Oncol"},{"key":"2502_CR20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JOP.2012.000597","volume":"8","author":"RS Lee","year":"2012","unstructured":"Lee RS, Bell CM, Singh JM, Hicks LK (2012) Hepatitis B screening before chemotherapy: a survey of practitioners\u2019 knowledge, beliefs, and screening practices. J Oncol Pract \/ Am Soc Clin Oncol 8:325\u2013328, 321 p following 328","journal-title":"J Oncol Pract \/ Am Soc Clin Oncol"},{"key":"2502_CR21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jvh.12305","volume":"22","author":"JP Hwang","year":"2015","unstructured":"Hwang JP, Barbo AG, Perrillo RP (2015) Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases. J Viral Hepat 22:346\u2013352","journal-title":"J Viral Hepat"},{"key":"2502_CR22","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3109\/10428194.2013.879712","volume":"55","author":"M Marignani","year":"2014","unstructured":"Marignani M, Marzano A, Begini P, Vitolo U, Luminari S, Levis A, Deli I, Gigante E, De Santis E, delle Fave G, Monarca B, Cox MC (2014) Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey. Leuk Lymphoma 55:2564\u20132571","journal-title":"Leuk Lymphoma"},{"key":"2502_CR23","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.3109\/10428194.2014.918973","volume":"55","author":"BW Teh","year":"2014","unstructured":"Teh BW, Sasadeusz JJ (2014) Guarding the sleeping giant: hepatitis b screening and management in patients with hematological malignancy. Leuk Lymphoma 55:2426\u20132427","journal-title":"Leuk Lymphoma"},{"key":"2502_CR24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50:661\u2013662","journal-title":"Hepatology"},{"key":"2502_CR25","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","volume":"94","author":"M Sandherr","year":"2015","unstructured":"Sandherr M, Hentrich M, von Lilienfeld-Toal M, Massenkeil G, Neumann S, Penack O, Biehl L, Cornely OA (2015) Antiviral prophylaxis in patients with solid tumours and haematological malignancies\u2014update of the guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol 94:1441\u20131450","journal-title":"Ann Hematol"},{"key":"2502_CR26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.cgh.2014.10.032","volume":"13","author":"CI Wi","year":"2015","unstructured":"Wi CI, Loo NM, Larson JJ, Moynihan TJ, Madde NR, Grendahl DC, Alberts SR, Kim WR (2015) Low level of hepatitis B virus screening among patients receiving chemotherapy. Clin Gastroenterol Hepatol 13:970\u2013975, quiz e951","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2502_CR27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jmv.10430","volume":"70","author":"W Yeo","year":"2003","unstructured":"Yeo W, Chan PK, Hui P, Ho WM, Lam KC, Kwan WH, Zhong S, Johnson PJ (2003) Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. J Med Virol 70:553\u2013561","journal-title":"J Med Virol"},{"key":"2502_CR28","doi-asserted-by":"crossref","first-page":"e0116978","DOI":"10.1371\/journal.pone.0116978","volume":"10","author":"WC Sun","year":"2015","unstructured":"Sun WC, Hsu PI, Yu HC, Lin KH, Tsay FW, Wang HM, Tsai TJ, Chen WC, Lai KH, Cheng JS (2015) The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system. PLoS One 10:e0116978","journal-title":"PLoS One"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2502-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2502-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2502-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:50:02Z","timestamp":1559022602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2502-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2502-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]}}}